Our reports and publications
Explore a selection of reports and publications from the Cancer Intelligence experts at Cancer Research UK, and through various collaborations.
Data Hubs | Covid-19 and Cancer | Treatment and post diagnosis | Risk factors and symptom awareness | Diagnosis and Screening | Cancer in the UK | Behavioural Science | Cancer Waiting Times |
Data Hubs
Local Stats Data Hub
The local stats data hub gives provides information across the cancer pathway for each constituency area based on publicly available data. It includes information on smoking prevalence, childhood overweight and obesity, bowel screening, cancer waiting times, cancer incidence and cancer mortality.
Cancer Waiting Times and Diagnostic Activity Data Hub
The CRUK Cancer Intelligence Team’s Cancer Waiting Times and Diagnostic Activity Data Hub gathers the latest data from across the UK on cancer waiting times performance and diagnostic activity and waiting times. You can view breakdowns for some of this information by a specific cancer site and country.
Early Diagnosis Data Hub
The CRUK Cancer Intelligence Team’s Early Diagnosis Data Hub gathers information and statistics across a number of cancer early diagnosis measures including incidence and survival by stage at diagnosis, screening uptake, urgent GP referrals and routes to diagnosis. You can view breakdowns for some of this information by a specific cancer site and country.
Children and Young People’s Cancers Data Hub
The CRUK Cancer Intelligence Team’s Children and Young People Cancer data hub uses data from Public Health England to provide a dashboard for cancer incidence and survival for 0–24-year-olds in the UK and its constituent nations. You can view data for each country by sex, age, main ICCC-3 diagnostic group and diagnostic subgroups.
Cancer Waiting Times
Performance measures across the cancer pathway: Key Stats
COVID-19’s effect on cancer patients is a key concern to the cancer community with delayed or decreased diagnosis, tests and treatment. To understand this variable and rapidly changing landscape the Cancer Intelligence team are regularly monitoring published data around the impact of the pandemic across the cancer pathway. We have prepared some key insights which reports latest data across the UK (and where possible for the devolved nations) on screening, urgent suspected referrals, diagnostic tests and treatment.
Cancer Intelligence Team, Cancer Research UK. Performance measures across the cancer pathway: Key Stats Updated October 2024
Cancer Waiting Times and Diagnostic Activity Data Hub
The CRUK Cancer Intelligence Team’s Cancer Waiting Times and Diagnostic Activity Data Hub gathers the latest data from across the UK on cancer waiting times performance and diagnostic activity and waiting times. You can view breakdowns for some of this information by a specific cancer site and country.
Which cancer patients experience long waits to treatment, and why?
NHS England has a target that at least 85% of patients should start their first treatment for cancer within 62 days of an urgent GP referral for suspected cancer. However, performance against this target has significantly deteriorated in recent years and the number of patients on this pathway waiting over 104 days has been increasing in recent years.
NHS England release monthly data summarising performance against Cancer Waiting Times (CWT) targets. However, these releases do not provide demographic breakdowns or allow an understanding of why lengthy waits are occurring. This project has used the detailed CWT dataset and the Rapid Cancer Registration Dataset to look at the demographics and other characteristics associated with patients who waited longer than 104 days in 2017/2018, 2020/2021, 2021/2022 and the first two quarters of 2022/2023, and the reported reasons for delay, to inform efforts to reduce the variation in long-waits and decrease their frequency overall, to ensure all patients receive timely treatment.
Wills, L. Cancer Intelligence Team, Cancer Research UK:
Breast cancer supplementary analysis Cancer of unknown primary supplementary analysis Gynaecological cancer supplementary analysis Haematological cancer supplementary analysis Head and neck cancer supplementary analysis Lower GI cancer supplementary analysis Lung cancer supplementary analysis Sarcoma supplementary analysis Skin cancer supplementary analysis Upper GI cancer supplementary analysis Urological cancer supplementary analysis
Covid-19 and Cancer
Impact of the COVID-19 pandemic on cancer surgery and cancer mortality
This research report from Telstra Health UK and Cancer Research UK explores the potential impact of the COVID-19 pandemic on cancer surgery and cancer mortality, both at the very beginning and throughout 18 months of living with the disruption, fear, and strain. The analysis reveals a general decrease in patients undergoing cancer surgery at the start of the pandemic for all demographic groups, but shows that for the most part the recovery period of the COVID-19 pandemic has not exacerbated inequalities in access to cancer surgery. However we know that there are disparities in access to treatment particularly by age, as well as some evidence of variation by deprivation and region. The report also highlights changes in cancer mortality and place of death. Overall it is shown that there was a profound and sustained impact on cancer services and patients but the true extent of these effects is not yet fully understood.
Cancer & COVID-19 Research Summit
Cancer Research UK (CRUK), The National Cancer Research Institute (NCRI) and Public Health England’s National Disease Registration Service (PHE NCRAS) hosted a Cancer/COVID-19 Research Summit with researchers from different disciplines to identify key research themes or questions around COVID-19’s impact on cancer prevention, early diagnosis and screening. Also, to discuss how the impact of COVID-19 on cancer patients can be mitigated through effective research.
Several areas in which further research is needed were identified, as well as lessons from the pandemic to improve research, cancer care, and help prepare for future crises. These include understanding the biological and psychological effects of COVID-19 on cancer patients, risk factors associated with COVID-19 and cancer, the influence of COVID-19 on health-related behaviours and the impact of COVID-19 on cancer care pathways. The full meeting report can be found here.
The impact of COVID-19 on cancer patients’ experience
This report summarises the findings from the CRUK patient experience survey (PES), which collected data from 1st May to 28th May 2020. The findings indicate the impact of COVID-19 on cancer patients, and their testing, treatment and care. For many cancer patients the COVID-19 pandemic appears to have had a significant impact on their testing and treatment, and most notably their care. This has resulted in a negative impact on the emotional well-being of many cancer patients whether they were hoping to finish their treatment, find out the results of their test, have their regular screening, or continue with care that could support them, in some cases for the remainder of their life.
Cancer Research UK. Cancer Research UK Cancer Experience Survey 2020: The impact of COVID-19 on Cancer patients in the UK. July 2020.
Treatment and post diagnosis
Geographic variation in treatment of endometrial Cancer
Our CRUK-PHE partnership team have investigated the geographic variation in the use of lymphonodectomy and external beam radiotherapy (EBRT) in the treatment of endometrial cancer. Significant variation was found between 19 Cancer Alliances using population level cancer registry data collected between 2013-2016, which is likely due to ambiguity in existing endometrial cancer management guidelines.
White B, Nordin A, Fry A et al. Geographic variation in the use of lymphadenectomy and external‐beam radiotherapy for endometrial cancer: a cross‐sectional analysis of population‐based data. BJOG 2019 doi: 10.1111/1471-0528.15914
Evaluating concordance with non-small cell lung and colon cancer NICE treatment guideline recommendations
Our CRUK – NHS England partnership team have investigated variation in concordance to recommendations from NICE treatment guidelines for colon and non-small cell lung cancer by patient characteristics and Cancer Alliance. Concordance differed between the recommendations, but there were generally associations between age group, comorbidity score, and stage and the likelihood of receiving recommended treatment.
Wills, L. Cancer Intelligence Team, Cancer Research UK:
Non-small cell lung cancer treatment guideline recommendation concordance report
Colon cancer treatment guideline recommendation concordance report
Risk factors and symptom awareness
Smoking prevalence projections 2021
Smoking is the leading cause of cancer and preventable death in the UK. Smoking prevalence has been declining across the UK for some decades, but remains higher in more deprived groups. The UK Government has set a smokefree ambition (to achieve 5% average adult smoking prevalence) for 2030 in England. There is currently no ambition to achieve smokefree in all deprivation groups.
In this report we estimate whether the smokefree 2030 ambition is likely to be realised based on recent trends, and when smokefree will be achieved for each deprivation decile. We have projected average adult smoking prevalence, and smoking prevalence by deprivation decile, for England until 2050. These projections use smoking prevalence data up to 2021, from the Office for National Statistics’ Annual Population Survey.
The results suggest that if recent trends continue, England will not reach smokefree until 2039, and to achieve the 2030 smokefree target, the pace of change needs to be around 70% faster than projected. The most deprived tenth of the population In England may be almost three decades behind the least deprived tenth, in achieving 5% smoking prevalence. This analysis suggests the pace of decline in smoking prevalence has slowed overall, and the deprivation gap has widened, since our previous projections using data to 2018.
Socio-economic deprivation and cancer incidence in England: Quantifying the role of smoking
Smoking is the leading cause of preventable cancer and death in the UK. Deprived populations typically experience higher rates of smoking and cancer incidence. We calculated the proportion and number of smoking-related cancer cases by deprivation quintile in England and modelled how smoking contributes to the deprivation gap for cancer incidence. We found a strong deprivation gradient for the proportion of cancer cases attributable to smoking in England. Our modelling suggests that more than half (61%) of the deprivation gap for cancer incidence could have been prevented if nobody smoked, indicating smoking to be the key driver for cancer incidence inequality in England.
Payne NWS, Brown KF, Delon C et al. Socio-economic deprivation and cancer incidence in England: Quantifying the role of smoking. PLOS ONE 2022 17(9): e0272202
Adult overweight and obesity prevalence projections for the UK
Overweight and obesity is a major risk factor for the leading causes of death in the world and is causally associated with at least 13 different types of cancer. Overweight and obesity prevalence has increased markedly in the UK in recent decades. We provide projections for overweight and obesity prevalence by sex and deprivation quintile in the UK (where possible) and its constituent nations. These projections, based on current trends in nationally representative health surveys, suggest that there could be more people who are obese than healthy weight in the UK by 2040. In England and Scotland, the deprivation gap for obesity between the least and most deprived is projected to increase by more than half.
Patients with non-specific symptoms
The CRUK-PHE partnership have published a paper comparing patients presenting with non-specific but concerning symptoms with patients presenting with more obvious symptoms. Cancer registration data was linked to the National Cancer and Diagnosis Audit (NCDA) data, which has information about primary care for over 17,000 cancers. The work found that patients with non-specific symptoms had longer primary care intervals, more complex diagnostic pathways and were more likely to be diagnosed at stage 4 and after an emergency presentation. This work supports the evaluation of Multi-Disciplinary Centres (MDCs) by the ACE Programme, an early diagnosis imitative supported by CRUK, MacMillan Cancer Support and NHS England.
Pearson C, Poirier V, Fitzgerald K, et al. Cross-sectional study using primary care and cancer registration data to investigate patients with cancer presenting with non-specific symptoms. BMJ Open 2020;10:e033008. doi: 10.1136/bmjopen-2019-033008
Cancers attributable to overweight and obesity by deprivation
This report investigates to what extent the proportion of overweight and obesity attributable cancer cases in the UK varies with deprivation. For females, the proportion of cancer cases attributable to overweight and obesity showed a 10-29% relative increase from the least deprived quintile to the most deprived. The deprivation gap was generally much smaller for males. There is a stronger deprivation gradient for obesity prevalence in UK females compared to males, and more overweight and obesity-associated cancer types in females compared to males, which explains the differences observed between sexes.
Cancer Intelligence Team, Cancer Research UK. The fraction of cancer attributable to overweight and obesity by deprivation quintile in the UK. October 2020.
Smoking prevalence projections
UK smoking prevalence has been declining overall for some decades, and ambitions to achieve 5% average adult smoking prevalence (‘smoke-free’) have been set by England for 2030, and Scotland for 2034. These projections, based on current trends in nationally-representative smoking surveys, suggest that 5% average adult smoking prevalence could be reached in 2037 for England and Wales, the late 2040s for Northern Ireland, and after 2050 for Scotland. There could be millions fewer UK smokers than projected in the 2030s, if smoke-free ambitions were achieved; however to do this the pace of change needs to increase markedly in all UK nations. Socioeconomic inequalities are a key concern: the projections indicate that in England, smoke-free could be achieved by the most deprived fifth of the population around 20 years later than in the least-deprived fifth; and in Scotland and Northern Ireland this deprivation gap may be markedly longer.
Cancer Intelligence Team, Cancer Research UK. Smoking prevalence projections for England, Scotland, Wales, and Northern Ireland based on data to 2018/19. February 2020.
Smoking trends by occupation group
The proportion of current smokers in the population (smoking prevalence) has been falling for decades in the UK, However a clear deprivation gradient remains: smoking prevalence is around twice as high in routine and manual (R&M) workers compared with managerial and professional (M&P) workers. That gap has widened in recent decades, because smoking prevalence has fallen more slowly among R&M workers compared with M&P workers. This reflects both higher rates of uptake and lower rates of quitting in R&M workers compared with M&P workers. Occupation group is associated with smoking behaviour independent of other characteristics like age, sex, region, education, marital status, ethnicity, alcohol consumption and general perceived health. If the R&M worker population had experienced the same pace of decline in smoking prevalence as the M&P population, there would now be almost a million fewer R&M worker smokers.
Cancer Intelligence Team 2019 Smoking prevalence trends by occupation group in health survey for England
Smoking prevalence projections 2021
Socio-economic deprivation and cancer incidence in England: Quantifying the role of smoking
Adult overweight and obesity prevalence projections for the UK
Patients with non-specific symptoms
Cancers attributable to overweight and obesity by deprivation
Smoking prevalence projections
Smoking trends by occupation group
Diagnosis and Screening
Relationship between ethnicity and stage at diagnosis
Our CRUK-NHS E partnership team have evaluated whether certain ethnic groups in England are more likely to be diagnosed at a later stage. Reviewing diagnoses of 6 cancer types from 2012-2016 in people belonging to one of 5 ethnic groups, we found that Caribbean, African and Asian women and Caribbean men had increased odds of late-stage disease for certain cancer types compared to the White British cohort. Reasons behind increased late diagnoses may include poorer symptom awareness, delays in seeking help and having to present to the GP multiple times before being referred for tests.
Fry A, White B, Nagarwalla D, et al. Relationship between ethnicity and stage at diagnosis in England: a national analysis of six cancer sites. BMJ Open 2023. doi: 10.1136/bmjopen-2022-062079
10-Year survival by stage for the East of England
In partnership with the National Cancer Registration Services (NCRAS), we have produced 10 year survival by stage estimates for the East of England. 10 year survival gives cancer patients a more accurate reflection of their long term survival experience and this work focuses on the differences in survival by stage at diagnosis. The work highlights the need for continued efforts to achieve diagnosis at earlier stages to improve longer term cancer outcomes. The results for lung, breast, bowel and prostate cancer are shown indicating 10 year survival is much poorer when diagnosed at the latest stage compared to the earlier stages. More information about the method used and wider range of site estimates produced can be found in this technical report.
Diagnostic Intervals in England
Our CRUK-PHE partnership team have calculated diagnostic intervals for the first time for patients of 25 different cancer sites diagnosed in 2014 & 2015. Significant variation in these intervals were found by stage of disease, route to diagnosis and comorbidity score. An online tool demonstrates variation by these and other factors by cancer site and cancer alliance. A paper describing the methodology and results for colorectal and lung cancer was published in Cancer Epidemiology in June 2019. Two blogs detailed the project, one by CRUK and one at Public Health Matters.
Pearson C, Fraser J, Peake M. Establishing population-based surveillance of diagnostic timeliness using linked cancer registry and administrative data for patients with colorectal and lung cancer. Cancer Epidemiology 2019.
Cancer in the UK
Cancer in the UK: Overview 2024
This report sets out the key challenges facing cancer services and people affected by cancer. We’ve made huge progress on cancer in the last 50 years, but new analysis indicates that improvements in survival have slowed. This next instalment in the Cancer in the UK series highlights the need for political leadership to deliver long-term solutions to the challenges facing cancer research and care.
Cancer in the UK: Overview 2024
Devolved nation summaries are also available:
Cancer in the UK: Scotland Overview 2024
Cancer in the UK: Overview 2023
This report sets out the top line view of key challenges facing cancer services, and people affected by cancer today, looking at where progress is being made and the many challenges we face. With cancer cases projected to rise, ensuring we have a long term, comprehensive plan for cancer that tackles these challenges and harnesses the opportunities is vital.
This report is a call to action – all of us must come together to make progress in our ambition to beat cancer. People affected by cancer deserve no less.
Cancer in the UK: Overview 2023
Devolved nation summaries are also available:
Cancer in the UK: Scotland Overview 2023
Cancer in the UK: Deprivation and cancer inequalities in Scotland
This report focuses on the impact of deprivation across the cancer pathway in Scotland. Generally, populations with higher deprivation have greater risk factors for cancer, are less aware of symptoms of cancer and report more barriers to seeking help. Their participation in screening programmes is lower and they are more likely to be diagnosed with late-stage disease. People from more deprived populations have worse cancer outcomes, including survival. We need to make sure we push to achieve lower levels of cancer risk factors, better engagement with the health system and improved cancer outcomes for everyone and close the deprivation gap, because beating cancer must mean beating it for everyone.
Cancer Intelligence Team, Cancer Research UK. Cancer in the UK: Deprivation and cancer inequalities in Scotland. November 2022.
Cancer in the UK: socio-economic deprivation
This report brings together the available evidence across the UK of inequalities in cancer by socio-economic variation and shows the negative experiences and outcomes that people from more deprived groups experience. Generally, populations with higher deprivation have higher prevalence of cancer risk factors, are less aware of symptoms of cancer and report more barriers to seeking help. Their participation in screening programmes is lower and they have higher proportions of cancer diagnosed through routes with worse survival. People from more deprived populations report worse experiences of care and experience inequalities in treatment options. They have worse outcomes. This report presents the evidence for each part of the cancer pathway with examples from all four UK nations.
Cancer Intelligence Team, Cancer Research UK. Cancer in the UK 2020: Socio-economic deprivation. September 2020.
Behavioural Science
Obesity Campaign Evaluation
Overweight and obesity’ is the second biggest preventable cause of cancer after smoking. In 2018, Cancer Research UK launched an awareness raising campaign about the link between overweight and obesity and cancer risk. This study aimed to evaluate the reach and impact of the campaign.The campaign consisted of six elements including the main message that ‘Obesity is a cause of cancer’. UK adults and Members of Parliament (MPs) were surveyed before the campaign (W1; n = 2124 and n = 151), 1 month (W2; n = 2050 and n = 151) and 3 months after the campaign (W3; n = 2059 and MPs not surveyed). Outcome measures were campaign reach, awareness of overweight and obesity as risk factors for cancer, attitudes towards individuals who are overweight or obese, support for policies to reduce obesity and reactions to the campaign. This evaluation suggests that the campaign achieved the primary objective of increasing awareness of the link between obesity and cancer without increasing negative attitudes towards individuals who are overweight or obese.
The effect and cost-effectiveness of mass media campaigns on health behaviour change: A narrative systematic review
Mass media campaigns can reach a large number of people with health messages, but it is unclear how effective these are at changing health behaviours. We conducted a narrative review of systematic reviews to examine the impact of mass media campaigns on eight health behaviours, as well as their cost-effectiveness. Specifically, we explored the impact of mass media campaigns on tobacco use, dietary behaviours, alcohol use, physical activity, sun and UV-protection, HPV vaccination, cancer screening uptake, and symptomatic GP presentation. We concluded that mass media campaigns should be used as part of multi-component, community-based interventions and more research is needed to assess the cost-effectiveness of these types of campaign.
Cancer Research UK Lung Cancer screening project
This report presents the data from the 2022 Lung Cancer Screening survey, led by Cancer Research UK (CRUK), conducted by YouGov and with the costs of the project covered by ScottishPower.
This piece of research aims to inform CRUK’s work in the lung cancer space. This may include taking action to support possible widespread introduction of targeted lung cancer screening by the NHS. It could also include work to mitigate any unintended consequences of targeted lung screening – such as impact on perceptions of the risk of lung cancer amongst people who have never smoked.
A bespoke survey was conducted to explore public perceptions around lung cancer and its risks, as well as knowledge and perceptions of screening, including eligibility and the impact of screening. This project built on previous work conducted by CRUK in order to optimise development of targeted lung cancer screening and ensure success of any future programme with minimised unintended consequences.
Evaluation: e-cigarette relative harms pilot campaign 2018
An advertising campaign piloted by Cancer Research UK in 2018 aimed to promote quit attempts by increasing awareness of the relative harms of e-cigarettes compared with smoking. A cross-sectional survey evaluation was conducted surveying adults (≥16 years, n = 2217) living in the campaign region and the comparison/control regions. We tested interactions between time (pre, post) and region (campaign, control).
Compared with the control region, the campaign was associated with an increase in smokers’ motivation to quit but a smaller increase in adults’ perception of e-cigarettes as an effective cessation aid. It was identified that using mass media to communicate accurate information about the relative harms of e-cigarettes compared with smoking may be an effective strategy in increasing smokers’ motivation to quit. Further research is needed to evaluate effects on quit attempts and success.
Harry Tattan-Birch, Sarah E Jackson, Charlotte Ide, et al. Evaluation of the Impact of a Regional Educational Advertising Campaign on Harm Perceptions of E-Cigarettes, Prevalence of E-Cigarette Use, and Quit Attempts Among Smokers. Nicotine Tob Res 2019. doi: 10.1093/ntr/ntz236
Image of standard packaging on cigarette boxes
In the United Kingdom, standardised packaging for cigarettes was phased in between May 2016 and May 2017. A cross-sectional online survey was conducted with current smokers aged 16+ in two regions of England when both standardised and fully-branded packs were available. The study found that standardised packaging was associated with increased warning salience and thoughts about risks and quitting. Specifically, compared with never users, current users were more likely to have noticed the warnings on packs often/very often, read them closely often/very often, thought somewhat/a lot about the health risks of smoking and thought somewhat/a lot about quitting. These findings provided support for standardised packaging during the transition period.
Moodie C, Brose LS, Lee HS et al. How did smokers respond to standardised cigarette packaging with new, larger health warnings in the United Kingdom during the transition period? A cross-sectional online survey. Addiction Research & Theory 2019.
Cancer awareness training evaluation
CRUK's training (“Talk Cancer”) aims to increase awareness of screening programmes and risk factors, promote more positive beliefs about cancer and increase confidence to discuss cancer with members of the public, among people working across the health service, local government, community and voluntary sectors who are appropriately placed to have these discussions with the public.
The evaluation found that the trainees' more positive beliefs about cancer, their increased confidence in discussing cancer and their increased awareness of bowel cancer screening were all maintained at 2 months.
Roberts A, Crook L, George H etc al. Two-month follow-up evaluation of a cancer awareness training workshop (“Talk Cancer”) on cancer awareness, beliefs and confidence of front-line public health staff and volunteers. Prev Med Rep 2019.
Exploring public views about delays in cancer screening
This report summarises the findings from an online survey (n=2,115), which contributes to discussions about the ethics of cancer screening in a pandemic situation. It aims to build an understanding of public attitudes towards cancer screening and any potential delays in cancer screening. The majority of participants (86%) wanted to know about any potential delays, and nearly half (48%) would prefer to experience a delay to their invitation over other parts of the screening pathway. The earlier in the pathway a delay is experienced the less anxiety participants anticipated.
This report supports a strategic delaying of cancer screening invitations under the proviso it ensures a shorter wait for follow-up tests and treatment. Ethical considerations about screening should include an emphasis on allowing the public to make an informed decision on their participation.
Exploring public attitudes towards the new Faster Diagnosis Standard for cancer
An exploration into public attitudes towards the new Faster Diagnosis Standard for cancer, due to be introduced in England in 2020, within the context of a patients’ recent referral experiences.
It found that waiting for test results and responsibility for meeting the standard were the main concerns and it was concluded that patients should be asked what they would like to know about their referral and that GPs should be more transparent about the referral process and the potential for a lack of clarity around next steps.
Piano M, Black G, Amelung D et al. Exploring public attitudes towards the new Faster Diagnosis Standard for cancer: a focus group study with the UK public. Br J Gen Pract 2019.
Want to generate bespoke preventable cancers stats statements? Download our interactive statement generator.
A theory and evidence-based redevelopment of a tool to support behaviour change
Research shows that leading a healthy lifestyle can help prevent cancer. Further, diagnosing cancer at an early stage can increase survival rates. Cancer Research UK (CRUK)'s nurse-led outreach activity supports cancer prevention, early diagnosis and screening in deprived community settings. CRUK developed a habit-based behaviour change tool to support this activity and better enable conversations about behaviour change.
Cancer Research UK’s Patient Survey 2021
Mass media campaigns can reach a large number of people with health messages, but it is unclear how effective these are at changing health behaviours. We conducted a narrative review of systematic reviews to examine the impact of mass media campaigns on eight health behaviours, as well as their cost-effectiveness. Specifically, we explored the impact of mass media campaigns on tobacco use, dietary behaviours, alcohol use, physical activity, sun and UV-protection, HPV vaccination, cancer screening uptake, and symptomatic GP presentation. We concluded that mass media campaigns should be used as part of multi-component, community-based interventions and more research is needed to assess the cost-effectiveness of these types of campaign.This report summarises the key findings from the CRUK Patient Survey, which collected data from December 2020 to March 2021. Findings are from patients who share their stories and experiences and give an indication of the impact COVID-19 has had on their testing, treatment and care. New data on remote consultations and COVID-19 safety measures have been collected.
The barriers to timely cancer diagnosis and treatment identified by people affected by cancer in this report are not an entirely new phenomenon that have emerged only in the pandemic. Even before COVID-19, cancer services were on the verge of crisis, and the vast majority of patients surveyed supported governments taking steps required to make expanding capacity in cancer services a reality.
Evaluating the impact of a community-based cancer awareness roadshow on awareness, attitudes and behaviors
Improving public awareness of cancer and encouraging health behavior change are important aspects of cancer control. We investigated whether a community-based roadshow was an effective way of communicating with the public about cancer and encouraging behavior change. Data were from 1196 people who completed questionnaires at a Cancer Research UK Cancer Awareness Roadshow in 2013. Of these, 511 (43%) completed questionnaires immediately before their visit (pre-visit group) and 685 (57%) completed questionnaires immediately after their visit (post-visit group). Among the post-visit sample, 217 (32%) were retained after two months. Self-reported data were available on risk factor and symptom awareness, help-seeking barriers, use of healthcare services and health behaviors. Compared with the pre-visit sample, the post-visit group had greater awareness of cancer risk factors and was more positive about aspects of help-seeking but awareness of potential symptoms was similar. Most effects were maintained over two months. Intentions to eat more fruit and vegetables and to exercise more were comparable between the groups but more people in the post-visit sample intended to quit smoking. At 2-month follow-up, smoking prevalence had significantly reduced but fruit and vegetable consumption decreased and there was no change to physical activity. User of weight loss services and general practitioner visits were high at follow-up and largely attributed to the Roadshow. The Cancer Research UK Roadshow appears to improve risk factor awareness, promote positive attitudes towards help-seeking and increase smoking cessation. This approach could be a useful building block for additional cancer prevention and control strategies.
What Drives Public Perceptions of E-cigarettes?
Despite growing evidence that e-cigarettes are less harmful than cigarettes, perceptions of equal or more harm have increased worldwide. This study aimed to identify the most common reasons behind people’s perceptions of the (i) relative harm of e-cigarettes compared with cigarettes and (ii) effectiveness of e-cigarettes for smoking cessation.
Cancer symptom experience and help-seeking behaviour during the COVID-19 pandemic in the UK
Objectives To understand self-reported potential cancer symptom help-seeking behaviours and attitudes during the first 6 months (March–August 2020) of the UK COVID-19 pandemic.
Design UK population-based survey conducted during August and September 2020. Correlates of help-seeking behaviour were modelled using logistic regression in participants reporting potential cancer symptoms during the previous 6 months. Qualitative telephone interviews with a purposeful subsample of participants, analysed thematically.
Intentions to participate in cervical and colorectal cancer screening during the COVID-19 pandemic
Worldwide, cancer screening faced significant disruption in 2020 due to the COVID-19 pandemic. If this has led to changes in public attitudes towards screening and reduced intention to participate, there is a risk of long-term adverse impact on cancer outcomes. In this study, we examined previous participation and future intentions to take part in cervical and colorectal cancer (CRC) screening following the first national lockdown in the UK.
Obesity Campaign Evaluation
The effect and cost-effectiveness of mass media campaigns on health behaviour change: A narrative systematic review
Cancer Research UK Lung Cancer screening project
Evaluation: e-cigarette relative harms pilot campaign 2018
Image of standard packaging on cigarette boxes
Cancer awareness training evaluation
Exploring public views about delays in cancer screening
Exploring public attitudes towards the new Faster Diagnosis Standard for cancer
A theory and evidence-based redevelopment of a tool to support behaviour change
Cancer Research UK’s Patient Survey 2021
Evaluating the impact of a community-based cancer awareness roadshow on awareness, attitudes and behaviors
What Drives Public Perceptions of E-cigarettes?
Cancer symptom experience and help-seeking behaviour during the COVID-19 pandemic in the UK
Intentions to participate in cervical and colorectal cancer screening during the COVID-19 pandemic
Join us on X (previously known as Twitter)
Join the conversation and follow @CRUKHCPs for news, updates and opinion. |